A phase III study of Inarigivir in patients with Hepatitis-B
Latest Information Update: 09 May 2019
At a glance
- Drugs Inarigivir soproxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Spring Bank Pharmaceuticals
Most Recent Events
- 09 May 2019 New trial record
- 29 Apr 2019 According to a Spring Bank Pharmaceuticals media release, the company anticipates to launch phase III program of Inarigivir for Hepatitis-B patients in the second half of 2020.